Dana Elfin

Dana Elfin is the Senior Legal Editor for Bloomberg BNA’s Pharmaceutical Law and Industry Report and Bloomberg BNA’s Medical Device and Law Report. A veteran reporter, Elfin has been covering the hottest legal and regulatory issues in the pharmaceutical/medical device industries since 1999, with a particular focus on Hatch-Waxman Act patent litigation and antitrust and constitutional law issues affecting the drug and device industries.